XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

What to Watch in the Day Ahead - Friday, October 25



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>What to Watch in the Day Ahead - Friday, October 25</title></head><body>

The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US. Thomson One users can register at RT/DAY/US. All times in ET/GMT

For the U.S. economy, the Commerce Department is expected to report that orders for durable goods likely fell 1.0% in September, after remaining unchanged in August. Another report will probably show that the University of Michigan's final reading on the overall index of consumer sentiment likely came in at 69 in October, compared with a preliminary reading of 68.9.


Federal Reserve Bank of Boston President Susan Collins will participate in a fireside chat on the Boston Fed's portfolio of work, supporting the Fed's Congressional mandates, and how various sectors – private, public, philanthropic, educational, and nonprofit – can collaborate to enhance economic vitality before the Black Economic Council of Massachusetts Black Expo in Boston. (1100/1500)


HCA Healthcare will report its third-quarter earnings. Investor focus is expected to be on demand for healthcare services at the hospital operator, labor costs as well as management commentary on the impact of the hurricane season on its operations.


Centene Corp is set to report third-quarter results before markets open. Investors and Wall Street analysts will focus on the health insurer's medical cost ratio - a unit that measures medical costs - and comments on the annual outlook as the industry grapples with elevated costs.


New York Community Bancorp is expected to report a third-quarter loss, driven by a steep decline in interest income and increased provisions for credit losses stemming from its significant exposure to commercial real estate. Investors will closely monitor cost-saving measures and management's comments regarding further reductions in the lender's CRE loan portfolio.


The U.S. Food and Drug Administration is expected to decide on approval for Iterum Therapeutics' oral drug to treat a type of urinary tract infection in women.


The Bank of Canada Governor Tiff Macklem will address journalists and answer questions in-person and virtually at the sidelines of the IMF meeting in Washington. (1430/1830)


Statistics Canada is due to release data on retail sales in the country which likely increased 0.5% in August, after recording a 0.9% rise in July.



Compiled by Ankita Yadav in Bengaluru; Editing by Vijay Kishore

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.